Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection

Cytokine

Volumn 53, Issue 3, 2011, Pages 282-285

  Baker, Rosalyn ^a,b   Dauner, Joseph G ^a   Rodriguez, Ana Cecilia ^c   Williams, Marcus C ^a   Kemp, Troy J ^a   Hildesheim, Allan ^d   Pinto, Ligia A ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adipokines; HPV; Inflammation; Persistent infection

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LEPTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD SAMPLING; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; WART VIRUS;

ADIPOKINES; ALPHAPAPILLOMAVIRUS; ANTIGENS, CD95; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RESISTIN; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 79251616890     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.014     Document Type: Article

References (20)

1. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev 2006, 6:772-783.
2. Siagris D., Vafiadis G., Michalaki M., Lekkou A., Starakis I., Makri M., et al. Serum adiponectin in chronic hepatitis C and B. J Viral Hepat 2007, 14:577-583.
3. Lebrecht A., Ludwig E., Huber A., Klein M., Schneeberger C., Tempfer C., et al. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol 2002, 85:32-35.
4. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003, 309:286-290.
5. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
6. Gainsford T., Willson T.A., Metcalf D., Handman E., McFarlane C., Ng A., et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A 1996, 93:14564-14568.
7. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004, 314:415-419.
8. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
9. Kemp T.J., Hildesheim A., Garcia-Pineres A., Williams M.C., Shearer G.M., Rodriguez A.C., et al. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2010, 19:1954-1959.
10. Herrero R., Schiffman M.H., Bratti C., Hildesheim A., Balmaceda I., Sherman M.E., et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste project. Rev Panam Salud Publica 1997, 1:362-375.
11. Bratti M.C., Rodriguez A.C., Schiffman M., Hildesheim A., Morales J., Alfaro M., et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica 2004, 15:75-89.
12. Garcia-Pineres A.J., Hildesheim A., Herrero R., Trivett M., Williams M., Atmetlla I., et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 2006, 66:11070-11076.
13. Kemp T.J., Garcia-Pineres A., Falk R.T., Poncelet S., Dessy F., Giannini S.L., et al. Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women. Vaccine 2008, 26:3608-3616.
14. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., Howard B.V. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab 2006, 91:64-68.
15. Burnett M.S., Lee C.W., Kinnaird T.D., Stabile E., Durrani S., Dullum M.K., et al. The potential role of resistin in atherogenesis. Atherosclerosis 2005, 182:241-248.
16. Garcia-Moreno C., Catalan M.P., Ortiz A., Alvarez L., De la Piedra C. Modulation of survival in osteoblasts from postmenopausal women. Bone 2004, 35:170-177.
17. Blanco-Colio L.M., Martin-Ventura J.L., de Teresa E., Farsang C., Gaw A., Gensini G., et al. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. Arterioscler Thromb Vasc Biol 2007, 27:168-174.
18. McTernan P.G., McTernan C.L., Chetty R., Jenner K., Fisher F.M., Lauer M.N., et al. J Clin Endocrinol Metab 2002, 87:2407.
19. Smith S.R., Bai F., Charbonneau C., Janderova L., Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003, 52:1611-1618.
20. Lacey J.V., Swanson C.A., Brinton L.A., Altekruse S.F., Barnes W.A., Gravitt P.E., et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003, 98:814-821.